Following BD's Biosciences & Diagnostic Solutions?
Get the free weekly contract digest
The latest new contracts, like BD's Biosciences & Diagnostic Solutions’s — who’s behind them and what they mean, delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New new contracts, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Contract Trends
See who's moving and how much in your market
No credit card required Weekly contract digest
BD and Biosero Partner to Integrate Robotic Automation with Flow Cytometers for Drug Discovery and Development
Jan 23, 2025•over 1 year ago
Contract Type
partnership
Description
BD and Biosero have announced a framework collaboration agreement to facilitate robotic arm integration with BD flow cytometry instruments, aiming to accelerate drug discovery and development. This partnership intends to develop new software capabilities within BD flow cytometer instrument software to be compatible with Biosero’s Green Button Go® software, as well as jointly support biopharmaceutical and contract research organizations with their custom research needs, enabling easy integration with robotic arms.
Company Information
Company
BD's Biosciences & Diagnostic Solutions
About
BD's Biosciences & Diagnostic Solutions is a division of Becton, Dickinson and Company. It focuses on developing tools and technologies for life sciences research. The division aims to provide innovative solutions for microbiology, immunology, and cellular analysis.
Predictive Intelligence
Strategic
ML-powered predictions for BD's Biosciences & Diagnostic Solutions's next move
